Advances in Nanomaterials in Biomedicine

Copper-Based Nanoparticles for Effective Treatment Against Sepsis-Induced Lung Injury in Mice Model

Introduction

Lung injury, a common complication of sepsis, arises from elevated reactive oxygen species (ROS), mitochondrial dysfunction, and cell death driven by inflammation. In this study, a novel class of ultrasmall nanoparticles (Cu4.5O USNPs) was developed to address sepsis-induced lung injury (SILI).

Methods

The synthesized nanoparticles were thoroughly characterized to assess their properties. In vitro experiments were conducted to determine the biologically effective concentration and elucidate the anti-inflammatory mechanism of action. These findings were further supported by in vivo studies, showcasing the material's efficacy in mitigating SILI.

Results

The Cu4.5O USNPs demonstrated remarkable scavenging capabilities for hydrogen peroxide (H2O2), superoxide anions (O2 -), and hydroxyl radicals (·OH), attributed to their catalase (CAT)- and superoxide dismutase (SOD)-like activities. Additionally, the nanoparticles exhibited strong anti-inflammatory effects, preserved mitochondrial homeostasis through potent ROS scavenging, and significantly reduced cell death. In vivo studies on mice further validated their protective role against SILI.

The conclusion

This study highlights the therapeutic potential of Cu4.5O USNPs in treating sepsis-induced lung injury by effectively scavenging ROS and reducing cell death. These findings provide compelling evidence for the future use of copper-based nanoparticles as antioxidant therapeutics.

Supramolecular Self-Assembled Nanostructures Derived from Amplified Structural Isomerism of Zn(II)-Sn(IV)-Zn(II) Porphyrin Triads and Their Visible Light Photocatalytic Degradation of Pollutants

Two structural isomeric porphyrin-based triads (Zn(II)porphyrin-Sn(IV)porphyrin-Zn(II)porphyrin) denoted as T1 and T2 were prepared from the reaction of meso-[5-(4-hydroxyphenyl)-10,15,20-tris(3,5-di-tert-butylphenyl)porphyrinato]zinc(II) (ZnL) with trans-dihydroxo-[5,10-bis(3-pyridyl)-15,20-bis(phenyl)porphyrinato]tin(IV) (SnP1) and trans-dihydroxo-[5,15-bis(3-pyridyl)-10,20-bis(phenyl)porphyrinato]tin(IV) (SnP2), respectively. All the compounds were characterized using UV-vis spectroscopy, emission spectroscopy, ESI-MS, 1H NMR spectroscopy, and FE-SEM. Most importantly, the two structurally isomeric porphyrin-based triads supramolecularly self-assembled into completely different nanostructures. T1 exhibits a nanosphere morphology, whereas T2 exhibits a nanofiber morphology. The amplified geometric feature in the structural isomeric porphyrin-based triads dictates the physical and chemical properties of the two triads. Both compounds showed the morphology-dependent visible light catalytic photodegradation of rhodamine B dye (74-97% within 90 min) and tetracycline antibiotic (44-71% within 45 min) in water. In both cases, the photodegradation efficiency of T2 was higher than that of T1. The present investigation can significantly contribute to the remediation of wastewater by tuning the conformational changes in porphyrin-based photocatalysts.

New horizons on advanced nanoscale materials for Cultural Heritage conservation

Nanomaterials have permeated numerous scientific and technological fields, and have gained growing importance over the past decades also in the preservation of Cultural Heritage. After a critical overview of the main nanomaterials adopted in art preservation, we provide new insights into some highly relevant gels, which constitute valuable tools to selectively remove dirt or other unwanted layers from the surface of works of art. In particular, the recent "twin-chain" gels, obtained by phase separation of two different PVAs and freeze-thawing, were considered as the most performing gel systems for the cleaning of Cultural Heritage. Three factors are crucial in determining the final gel properties, i.e., pore size, pore connectivity, and surface roughness, which belong to the micro/nanodomain. The pore size is affected by the molecular weight of the phase-separating PVA polymer, while pore connectivity and tortuosity likely depend on interconnections formed during gelation. Tortuosity greatly impacts on cleaning capability, as the removal of matter at the gel-target interface increases with the uploaded fluid's residence time at the interface (higher tortuosity produces longer residence). The gels' surface roughness, adaptability and stickiness can also be controlled by modulating the porogen amount or adding different polymers to PVA. Finally, PVA can be partially replaced with different biopolymers yielding gels with enhanced sustainability and effective cleaning capability, where the selection of the biopolymer affects the gel porosity and effectiveness. These results shed new light on the effect of micro/nanoscale features on the cleaning performances of "twin-chain" and composite gels, opening new horizons for advanced and "green"/sustainable gel materials that can impact on fields even beyond art preservation, like drug-delivery, detergency, food industry, cosmetics and tissue engineering.

Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases

Dramatic advancement has been made in recent decades to understand the basis of autoimmunity-mediated neurological diseases. These diseases create a strong influence on the central nervous system (CNS) and the peripheral nervous system (PNS), leading to various clinical manifestations and numerous symptoms. Multiple sclerosis (MS) is the most prevalent autoimmune neurological disease while NMO spectrum disorder (NMOSD) is less common. Furthermore, evidence supports the presence of autoimmune mechanisms contributing to the pathogenesis of amyotrophic lateral sclerosis (ALS), which is a neurodegenerative disorder characterized by the progressive death of motor neurons. Additionally, autoimmunity is believed to be involved in the basis of Alzheimer’s and Parkinson’s diseases. In recent years, the prevalence of autoimmune-based neurological disorders has been elevated and current findings strongly suggest the role of pharmacotherapies in controlling the progression of autoimmune diseases. Therefore, this review focused on the current advancement of immunomodulatory drugs as novel approaches in the management of autoimmune neurological diseases and their future outlook.